Why Medline Inc. (MDLN) Stock Rose 18.4% on Nov 4, 2026
What happened
Medline reported Q3 2026 earnings (Globe Newswire, Nov 4), driving a +13.02% intraday surge from $34.09 to $38.53. Volume reached 4.07M shares (2.54x historical average at this time of day), signaling strong investor response to the results announcement.
Medline's formal 10-Q filing and any updates on the scope or progress of the product quality investigation; also monitor for analyst revisions following the earnings release.
Other developments that session
Medline Inc. (MDLN) reported EPS of $0.44 vs. consensus estimate of $0.34 for Q3 FY2026, beating consensus by 28.2%.
Medline Inc. (MDLN) filed an 8-K on November 4, 2026. The audit found no earnings announcement, analyst updates, or corporate action details in the filing.
Medline reported Q3 2026 earnings with top- and bottom-line results versus Wall Street estimates.
Frequently asked questions
Why did Medline Inc. (MDLN) stock rise on Nov 4, 2026?
Medline reported Q3 2026 earnings (Globe Newswire, Nov 4), driving a +13.02% intraday surge from $34.09 to $38.53. Volume reached 4.07M shares (2.54x historical average at this time of day), signaling strong investor response to the results announcement.
How much did MDLN stock rise on Nov 4, 2026?
MDLN rose 18.4% during the Nov 4, 2026 trading session.